Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Pulmonary Embolism (Disorder)”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableStudy completedNCT01602445
What this trial is testing

Pro-coagulant Markers and Anticoagulant Failure in Cancer Patients at Risk for Recurrence of Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute 700
Not applicableStudy completedNCT01871194
What this trial is testing

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Professor Saad Shakir 3,400
Not applicableStudy completedNCT00720915
What this trial is testing

D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
McMaster University 410
Large-scale testing (Phase 3)Ended earlyNCT00182247
What this trial is testing

D-Dimer and IPG for Recurrent Thrombosis (DIRECT)

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Hamilton Health Sciences Corporation 600
Post-approval studies (Phase 4)Study completedNCT00457158
What this trial is testing

PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava Interruption

Who this might be right for
Pulmonary EmbolismVenous Thrombosis
Centre Hospitalier Universitaire de Saint Etienne 399
Large-scale testing (Phase 3)UnknownNCT00222677
What this trial is testing

Aspirin for the Prevention of Recurrent Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism+1 more
University Of Perugia 70
Large-scale testing (Phase 3)Study completedNCT00558259
What this trial is testing

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE

Who this might be right for
Venous Thromboembolism
Boehringer Ingelheim 1,353
Post-approval studies (Phase 4)Study completedNCT04168203
What this trial is testing

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Who this might be right for
Deep Vein ThrombosisPulmonary EmbolismVenous Thromboembolism
Brigham and Women's Hospital 600
Not applicableStudy completedNCT02884934
What this trial is testing

Six Years of Follow-up After Idiopathic Venous Throbmoembolism

Who this might be right for
Pulmonary EmbolismProximal Deep Vein Thrombosis
University Hospital, Brest 409
Not applicableWithdrawnNCT03812835
What this trial is testing

Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment

Who this might be right for
Thrombosis, Deep VeinPulmonary Embolism
Pfizer
Large-scale testing (Phase 3)Study completedNCT00740883
What this trial is testing

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.

Who this might be right for
Pulmonary Embolism
University Hospital, Brest 374
Not applicableStudy completedNCT00266045
What this trial is testing

D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of Recurrence

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 355
Not applicableStudy completedNCT05413317
What this trial is testing

Contribution of Lower Limb Venous Colour Doppler Ultrasound in the Diagnosis of Pulmonary Embolism Recurrence

Who this might be right for
Pulmonary Embolism
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 115
Large-scale testing (Phase 3)Study completedNCT05515120
What this trial is testing

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Who this might be right for
Venous ThromboembolismAnticoagulant-induced BleedingVenous Thromboses+1 more
Instituto Mexicano del Seguro Social 58
Large-scale testing (Phase 3)WithdrawnNCT01164540
What this trial is testing

Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis

Who this might be right for
Venous ThrombosisPulmonary Embolism
AstraZeneca 3,000
Not applicableStudy completedNCT02345343
What this trial is testing

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Bristol-Myers Squibb 100
Not applicableStudy completedNCT00011180
What this trial is testing

Risk Factors for Venous Thromboembolism in the Community

Who this might be right for
Cardiovascular DiseasesThromboembolism
Mayo Clinic 385
Not applicableUnknownNCT03091621
What this trial is testing

Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients With Deep Vein Thrombosis and Pulmonary Embolism

Who this might be right for
Deep Vein ThrombosisPulmonary Embolism
Nihon University 1,000
Not applicableStudy completedNCT00670540
What this trial is testing

Epidemiology of Thromboembolism Disease: A Cohort Study

Who this might be right for
Vascular DiseasesEmbolism and ThrombosisPhlebitis+2 more
University Hospital, Grenoble 8,256
Not applicableLooking for participantsNCT06372730
What this trial is testing

Residual Pulmonary Vascular Obstruction Index Computed with Ventilation/perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients with Pulmonary Embolism (PRONOSPECT)

Who this might be right for
Pulmonary EmbolismVenous Thromboembolism
University Hospital, Brest 665
Load More Results